Charles Schwab
FCSC

Charles Schwab’s Fibrocell Science Inc. FCSC Stock Holding History

Charles Schwab’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,330
Closed -$88K – 3159
2016
Q1 		$88K Hold
2,330
– – ﹤0.01% 2998
2015
Q4 		$159K Hold
2,330
– – ﹤0.01% 2998
2015
Q3 		$135K Hold
2,330
– – ﹤0.01% 3009
2015
Q2 		$185K Buy
+2,330
New +$157K ﹤0.01% 2989
2014
Q2 		– Sell
-1,600
Closed -$126K – 3163
2014
Q1 		$126K Hold
1,600
– – ﹤0.01% 3020
2013
Q4 		$98K Hold
1,600
– – ﹤0.01% 3058
2013
Q3 		$104K Hold
1,600
– – ﹤0.01% 3030
2013
Q2 		$145K Buy
+1,600
New +$132K ﹤0.01% 2994

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab's FCSC Position: Q2 2016 in Review

Charles Schwab sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 2,330 shares — an estimated $88K sold.

Charles Schwab first reported a position in FCSC in Q2 2013 and held it in 8 quarters. The position peaked at $185K in Q2 2015. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

  • Charles Schwab reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
  • Charles Schwab sold 2,330 Fibrocell Science Inc. shares in Q2 2016, an estimated $88K.
  • Charles Schwab first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 8 quarters.
  • Charles Schwab's Fibrocell Science Inc. position peaked at $185K in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.